New human data hints at psychedelics' potential to combat inflammation
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
Europe faces threat of organised sabotage, terrorist attacks: Estonian FM Tsahkna
Estonia's counterintelligence service has recently warned that sabotage operations orchestrated by Russian special services have reached a new and dangerous phase in Europe, with targets no longer being purely symbolic. Talking Europe sits down with the country's foreign minister, Margus Tsahkna, to discuss the security situation in Estonia and the European Union in general.
Breakingviews - COMMENTARY: Tech stocks sound an uncomfortable 2008 echo
The industry is now 40% of the S&P 500. A sharp sell-off on AI fears is a reminder that such lop-sidedness marked prior booms and busts. Unlike the dotcom era, frenzied activity is lifting earnings faster than valuations. The financial crisis shows that this can be a bigger risk.
Log in or sign up to comment.